Physician profile
Christopher K Mocek
NPI 1821050618
$10,247.01
in general payments reported to CMS, 2019-2025
39 companies · $3,274 in 2025
The $3,274 reported for 2025 was more than what 87% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,342 · 2020: $1,390 · 2021: $486 · 2022: $430 · 2023: $1,751 · 2024: $574 · 2025: $3,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,936 · Food and Beverage: $2,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,935.78 |
| Food and Beverage | $2,662.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,607.06 | 2019-2025 | Proclaim |
| Flowonix Medical Incorporated | $949.36 | 2019 | |
| Biodelivery Sciences International, INC. | $944.20 | 2019-2021 | |
| Relievant Medsystems, INC. | $863.22 | 2023 | Intracept |
| Nevro Corp. | $836.58 | 2019-2023 | Senza |
| Si-Bone, INC. | $817.49 | 2025 | |
| Boston Scientific Corporation | $534.80 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $529.75 | 2019-2025 | Belbuca, Xtampza |
| Stryker Corporation | $496.67 | 2025 | Optablate |
| Vertos Medical, INC. | $287.93 | 2021-2023 | Mild Device Kit |
| Pfizer INC. | $255.37 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $252.13 | 2019-2024 | Relistor |
| Spr Therapeutics, INC | $204.63 | 2019-2024 | Sprint Pns System |
| Idorsia Pharmaceuticals US INC | $192.41 | 2022-2024 | Quviviq |
| Saluda Medical Americas, INC. | $191.74 | 2024-2025 | Evoke |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mocek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.